Pharmacokinetics and therapeutic effects
โ
Soo K. Bae; Shin J. Lee; Taekrho Kim; Jin W. Kim; Inchul Lee; Sang G. Kim; Myung
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 160 KB
Pharmacokinetics and therapeutic effects of oltipraz were evaluated after consecutive (once per day at 30 mg/kg/day for 7 and 14 days) or intermittent (once per week at 100 mg/kg/week for 1-3 weeks) oral administration to rats with liver cirrhosis induced by dimethylnitrosamine. The AUC of oltipraz